Central Venous Catheters (CVCs)

Global Central Venous Catheters (CVCs) Market to Reach US$2.0 Billion by 2030

The global market for Central Venous Catheters (CVCs) estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Multi-Lumen, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$971.4 Million by the end of the analysis period. Growth in the Triple-Lumen segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$463.2 Million While China is Forecast to Grow at 7.8% CAGR

The Central Venous Catheters (CVCs) market in the U.S. is estimated at US$463.2 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$240.8 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Central Venous Catheters (CVCs) Market - Key Trends & Drivers Summarized

Central Venous Catheters (CVCs) are critical medical devices used for administering medication, fluids, blood products, and parenteral nutrition, as well as for hemodialysis and monitoring central venous pressure. These catheters are inserted into a large vein, typically in the neck (internal jugular vein), chest (subclavian vein), or groin (femoral vein), and threaded through to the central veins near the heart. CVCs are indispensable in the management of patients with severe illnesses, those undergoing major surgeries, and those requiring long-term intravenous therapy. They provide a reliable and long-term intravenous access point, crucial for the delivery of life-saving treatments and accurate hemodynamic assessment.

Advancements in CVC technology have led to significant improvements in their safety, efficacy, and ease of use. Modern CVCs are designed with features that minimize the risk of infection and mechanical complications. Antimicrobial-coated catheters, for instance, have been developed to reduce the incidence of catheter-related bloodstream infections (CRBSIs), a major concern in clinical practice. Additionally, advancements in catheter materials and insertion techniques have enhanced the durability and biocompatibility of CVCs. The use of ultrasound guidance for catheter placement has become standard practice, significantly reducing insertion-related complications and improving the success rate of the procedure. These technological and procedural innovations have made CVCs safer and more reliable for both patients and healthcare providers.

The growth in the central venous catheters market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in medical technology, and the rising number of surgical procedures. The global rise in chronic conditions such as cancer, kidney disease, and heart failure has led to a higher demand for long-term intravenous therapies, consequently boosting the need for CVCs. Technological advancements have resulted in the development of more sophisticated and safer CVCs, which have enhanced their adoption in clinical settings. Furthermore, the growing number of surgical procedures and the expanding geriatric population, who are more likely to require intensive medical care, have further fueled market growth. The increasing focus on infection prevention and the development of antimicrobial and anti-thrombogenic coatings for CVCs are also contributing to the market`s expansion. These factors, combined with ongoing research and development efforts to improve catheter design and functionality, are driving the robust growth of the central venous catheters market.

SCOPE OF STUDY:

The report analyzes the Central Venous Catheters (CVCs) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Design (Multi-Lumen, Triple-Lumen, Double-Lumen, Single-Lumen); Property (Non-Antimicrobial Coated, Antimicrobial Coated); Application (Jugular Vein, Femoral Vein, Subclavian Vein); End-Use (Hospitals, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 61 Featured) -

• GE Healthcare
• ConMed Corporation
• Edwards Lifesciences Corporation
• Biosensors International Group Ltd.
• ICU Medical, Inc.
• FUJIFILM SonoSite, Inc.
• Biometrix BV
• Bactiguard
• Global Medikit Ltd.
• Comed B.V.
• Foshan Special Medical Co., Ltd.
• Guangdong Baihe Medical Technology Co., Ltd.
• Biotronix Healthcare, Inc.
• Bionic Medizintechnik GmbH
• HEKA Srl

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.